{"id":8838,"date":"2018-09-25T14:27:09","date_gmt":"2018-09-25T14:27:09","guid":{"rendered":"https:\/\/crigroup.com\/?post_type=case-study&p=8838"},"modified":"2022-03-30T08:40:04","modified_gmt":"2022-03-30T08:40:04","slug":"iso-37001-for-life-science-industry","status":"publish","type":"case-study","link":"https:\/\/crigroup.com\/ar\/case-study\/iso-37001-for-life-science-industry\/","title":{"rendered":"How can life sciences companies prevent bribery and corruption with compliance? Is ISO 37001 the answer?"},"content":{"rendered":"

ISO 37001 for the life science industry<\/strong><\/h3>\n

ISO 37001 for the life science industry. Does ISO 37001 Anti-bribery Management Systems (ABMS) be able to eradicate unethical practices in the life sciences industry? Given the crucial role that healthcare plays in society, the impact of unethical and\/or illegal behaviour can be particularly harmful.<\/p>\n

CRI Group (parent brand of ABAC) has conducted an empirical review of international laws and conventions; professional association codes; and individual company Anti-Bribery and Anti-Corruption policies, as well as conducting in-depth interviews with ABAC and Life Sciences legal professionals, in order to validate the efficacy of existing measures, and to identify gaps in good practice and enforcement.<\/p>\n

The ebook analysed several aspects including:<\/strong><\/h3>\n